Vimarsana
Biggest News Aggregation in the World

Page 27 - Query Get News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Query Get. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Query Get Today - Breaking & Trending Today

Participation in cardiac rehabilitation after AVR varies greatly across hospitals - Vimarsana News

Participation in cardiac rehabilitation after AVR varies greatly across hospitals

Participation in cardiac rehabilitation following surgical or transcatheter aortic valve replacement varies greatly from hospital to hospital, although researchers observed a correlation between participation and treatment strategy.In a presentation at the American Heart Association Quality of Care and Outcomes Research Scientific Sessions, researchers showed that participation in cardiac

Source: healio.com
Pacira BioSciences reports financial results for first-quarter 2022 - Vimarsana News

Pacira BioSciences reports financial results for first-quarter 2022

Pacira BioSciences Inc. reported increased total revenue and net product sales in its first-quarter 2022 financial results, according to a press release.The company reported a net income of $6.8 million and a total revenue of $158 million, an increase of 33% from the prior year period. Net product sales were $129.2 million for Exparel, $23.6 million for Zilretta and $3 million for Iovera,

Source: healio.com
Pregnancy within 12 months of ultrasound ascertainment more common with malpositioned IUD - Vimarsana News

Pregnancy within 12 months of ultrasound ascertainment more common with malpositioned IUD

SAN DIEGO — Patients with a malpositioned IUD had a higher risk for pregnancy within 12 months of ultrasound IUD ascertainment compared with patients with properly positioned IUDs, according to data presented here.

Source: healio.com
FDA approves tirzepatide, first dual incretin agonist for type 2 diabetes - Vimarsana News

FDA approves tirzepatide, first dual incretin agonist for type 2 diabetes

The FDA announced it approved the injectable dual incretin agonist tirzepatide to improve glucose response in adults with type 2 diabetes in addition to diet and exercise.Tirzepatide (Mounjaro, Eli Lilly) is a first-in-class medicine that activates both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, which leads to improved glucose control. Tirzepatide is injected once

Source: healio.com
Sex steroid levels, bone markers align with skeletal development in boys during puberty - Vimarsana News

Sex steroid levels, bone markers align with skeletal development in boys during puberty

Serum levels of sex steroids and bone metabolism markers align with skeletal development in boys during puberty, though development can vary based on pubertal stage, according to study findings published in Bone. “Serum levels of sex steroids, insulin-like growth factor I and bone metabolism markers reflect skeletal development during puberty,” Bruno Lapauw, MD, PhD, professor in the

Source: healio.com